ANESIVA

anesiva-logo

Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management worldwide. Its lead product candidate includes Adlea, which completed multiple Phase II and Phase III trials for post-surgical, musculoskeletal, and neuropathic pain. The company was formerly known as AlgoRx Pharmaceuticals, Inc., it changed its name to Anesiva, Inc. in 2006. Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, 2010, Anesiva, Inc. filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the Northern District of California. On June 10, 2014 filed for Chapter 7 bankruptcy.

#People #Financial #Website #More

ANESIVA

Social Links:

Industry:
Biotechnology Genetics Health Care Medical Therapeutics

Founded:
1999-01-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.anesiva.com

Total Employee:
51+

Status:
Closed

Contact:
650-624-9600

Total Funding:
113.37 M USD

Technology used in webpage:
Clicky


Founder


not_available_image

John McLaughlin

Stock Details


Company's stock symbol is NASDAQ:CGTK

Acquisitions List

Date Company Article Price
2005-09-26 AlgorX AlgorX acquired by Anesiva N/A

Investors List

alta-partners_image

Alta Partners

Alta Partners investment in Post-IPO Equity - Anesiva

interwest-partners_image

InterWest Partners

InterWest Partners investment in Series D - Anesiva

alta-partners_image

Alta Partners

Alta Partners investment in Series D - Anesiva

j-p-morgan-partners_image

JPMorgan Partners

JPMorgan Partners investment in Series D - Anesiva

temasek_image

Temasek Holdings

Temasek Holdings investment in Series C - Anesiva

hbm-healthcare-investments-ag_image

HBM Healthcare Investments

HBM Healthcare Investments investment in Series C - Anesiva

interwest-partners_image

InterWest Partners

InterWest Partners investment in Series C - Anesiva

bear-stearns-health-innoventures-l-p_image

Bear Stearns Health Innoventures L.P

Bear Stearns Health Innoventures L.P investment in Series C - Anesiva

alta-partners_image

Alta Partners

Alta Partners investment in Series C - Anesiva

j-p-morgan-partners_image

JPMorgan Partners

JPMorgan Partners investment in Series C - Anesiva

Official Site Inspections

http://www.anesiva.com Semrush global rank: 6.66 M Semrush visits lastest month: 1.05 K

  • Host name: 172.67.221.129
  • IP address: 172.67.221.129
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Anesiva"

Anesiva - Crunchbase Company Profile & Funding

AlgoRx Pharmaceuticals, Inc., it changed its name to Anesiva, Inc. in 2006. Anesiva, Inc. was founded in 1999 and is headquartered in South San Francisco, California. On January 15, …See details»

Corporate - Anesiva

Anesiva, Inc. (Nasdaq: ANSV) is a late-stage biopharmaceutical company focused on the development and commercialization of novel pharmaceutical products for pain management. …See details»

Anesiva Company Profile - Office Locations, Competitors ... - Craft

Anesiva (formerly AlgoRx Pharmaceuticals) is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutic treatments for pain. Its lead …See details»

Anesiva - Investor Relations

Nov 11, 2008 Investor Relations. Anesiva, Inc. (Nasdaq: ANSV) is a biopharmaceutical company focused on the development and commercialization of novel therapeutic treatments for pain …See details»

Anesiva - Contacts, Employees, Board Members, Advisors & Alumni

Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for painSee details»

ANESIVA INC. Company Profile | South San Francisco, CA

Find company research, competitor information, contact details & financial data for ANESIVA INC. of South San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»

Organization | Anesiva, Inc. - Purdue University

Organization Overview. First Clinical Trial. 2001 NCT00041925. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Key: Anesiva, Inc. (2) Acquired (2) 4975 ...See details»

Anesiva - Ownership and Business Overview - Mergr

Anesiva is headquartered in South San Francisco, California. How many employees does Anesiva have? Anesiva has 78 employees. What sector is Anesiva in? Anesiva is a life science …See details»

Anesiva - Products, Competitors, Financials, Employees, …

Anesiva, formerly Corgentech Inc., is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. …See details»

Anesiva - Funding, Financials, Valuation & Investors - Crunchbase

Anesiva is registered under the ticker NASDAQ:CGTK . Their stock opened with $16.00 in its Feb 12, 2004 IPO. Anesiva is funded by 7 investors. Alta Partners and InterWest Partners are the …See details»

Anesiva Overview | SignalHire Company Profile

Anesiva is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel pharmaceutical products for pain management. …See details»

Anesiva, Inc. - VentureRadar

Anesiva, Inc. VentureRadar profile. Find out more about Anesiva, Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more. ... Ardena Belgium n/a Ardena is …See details»

Anesiva says to seek bankruptcy after deal fails | Reuters

Dec 31, 2009 Anesiva Inc <ANSV.O>, a developer of pharmaceutical products for chronic pain, said on Thursday it will file for bankruptcy after it was unable to complete a proposed merger …See details»

Anesiva Inc. Company Profile | South San Francisco, CA

Anesiva Inc. Company Profile | South San Francisco, CA | Competitors, Financials & Contacts - Dun & BradstreetSee details»

Anesiva, Inc. (Anesiva, Inc.) - 药物管线_专利_临床试验_投融营收

Prior to joining Fibrogen, Dr. Yu was Vice President and Head of Clinical Research at Anesiva, Inc. (formerly known as Corgentech, Inc., (NASDAQ: ANSV)), where she was responsible for …See details»

Anesiva Outlines Comprehensive Commercialization Plan For FDA …

Oct 14, 2007 Anesiva, Inc. recently announced key elements of the company's commercialization and launch plans for Zingo (lidocaine hydrochloride monohydrate) powder …See details»

ANESIVA INC San Francisco CA, 94108 - Company Profile - Cortera

Free Business profile for ANESIVA INC at 800 Powell St, San Francisco, CA, 94108-2006, US. ANESIVA INC specializes in: Pharmaceutical Preparations. This business can be reached at …See details»

Anesiva, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Last update 08 Mar 2025. Anesiva, Inc. Private Company | Subsidiary Company |See details»

What is Anesiva? Company Culture, Mission, Values | Glassdoor

See what employees say it's like to work at Anesiva. Salaries, reviews, and more - all posted by employees working at Anesiva.See details»

linkstock.net © 2022. All rights reserved